Insider Monkey1d agoneutral
Some Experts Think TransMedics Group (TMDX) Has a Near-Monopoly on Keeping Donor Organs AliveNews
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
105last 24h
3127last 7d
510● bullish (7d)
311● bearish (7d)
227publishers
Schaeffer's Investment Research2d agoneutral
Unusual Options Volume Report: 3 Stocks Moving After EarningsGuruFocus.com2d agoneutral
TransMedics Group Inc (TMDX) (Q3 2026) Earnings Call Highlights: Record $203 Million Revenue ...PR Newswire9d agoneutral
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)PR Newswire17d agoneutral
TransMedics to Report Third Quarter 2026 Financial Results on November 5, 2026Simply Wall St.22d agoneutral
TransMedics Group (TMDX) Stock Looks Undervalued On Current EarningsSimply Wall St.37d agoneutral
TransMedics Group (TMDX) Could Be 19% Undervalued If Its Growth Narrative HoldsMT Newswires59d agoneutral
TransMedics Names Fernando Araujo as CFO; Maintains 2026 Revenue OutlookMarketBeat82d agoneutral
TransMedics Targets $2B Opportunity With Kidney Push, European ExpansionSimply Wall St.95d agoneutral
TransMedics Group (TMDX) Stock Looks Cheap On Earnings But Full After 171% GainGuruFocus.com95d agoneutral
TransMedics Group Inc (TMDX) (Q2 2026) Earnings Call Highlights: Record Revenue and Strategic ...Simply Wall St.96d agoneutral
Is UBS Coverage and New Equity Awards Reframing TransMedics’ (TMDX) Transplant Platform Narrative?